---
Investor Relations

About Awakn


Awakn Life Sciences is a clinical-stage biotechnology company developing therapeutics to treat addiction, with a near-term focus on Alcohol Use Disorder.

We are focused on treating addiction because it is a significant unmet medical need driven by high prevalence rates and high relapse rates.

Awakn Life Sciences Corp. Stock Price (NEO)
Information provided by Stockdio.

 

 

Awakn corporate information

Download latest Awakn Corporate Presentation and visit Awakn Financials Info on Sedar.

acp

Analyst Coverage

FIRM

Stifel

Maxim Group LLC

ANALYST

Andrew Partheniou

Jason McCarthy

Press releases

Awakn Life Sciences Signs Drug Development Agreement With Catalent For Zydis® Technology (An Orally Disintegrating Tablet) To Conduct Feasibility Studies To Improve Differentiation Of Its MDMA Program

Awakn Life Sciences Signs Drug Development Agreement with Catalent for Zydis® Technology (An Orally Disintegrating Tablet) to Conduct Feasibility Studies to Improve Differentiation of its MDMA Program

TORONTO, CANADA, Sept, 12 2022 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on…

Enquiries

Investor relations:

Anthony Tennyson
CEO, Awakn Life Sciences
anthony.tennyson@awaknlifesciences.com

Media enquiries:

Gordo Whittaker,
CMO, Awakn Life Sciences

gordo@awaknlifesciences.com

Sign Up for Newsletter

Awakn_logo_corp

MAIN OFFICE
Awakn Life Sciences Corp.
301-217 Queen St. W
Toronto, Ontario M5V 0R2
Canada

© 2023 Awakn Life Sciences Corp      |      Privacy Policy      |      Appropriate Use Policy

Back to top Arrow